Frontier Capital Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-438,693
Closed -$7.55M 297
2018
Q3
$7.55M Buy
438,693
+361,232
+466% +$5.37M 0.05% 255
2018
Q2
$1.08M Sell
77,461
-447,711
-85% -$7.56M 0.01% 295
2018
Q1
$8.05M Buy
525,172
+248,888
+90% +$3.56M 0.06% 251
2017
Q4
$3.18M Buy
276,284
+160,701
+139% +$2.39M 0.02% 274
2017
Q3
$2.2M Sell
115,583
-332,990
-74% -$6.85M 0.02% 279
2017
Q2
$10.8M Sell
448,573
-66,941
-13% -$1.47M 0.08% 235
2017
Q1
$10.2M Sell
515,514
-109,472
-18% -$2.44M 0.08% 238
2016
Q4
$15.1M Buy
624,986
+527,405
+540% +$14.7M 0.12% 210
2016
Q3
$2.71M Buy
97,581
+5,964
+7% +$158K 0.02% 281
2016
Q2
$2.23M Sell
91,617
-404,996
-82% -$11.5M 0.02% 282
2016
Q1
$16.7M Buy
496,613
+193,512
+64% +$6.09M 0.13% 203
2015
Q4
$9.06M Sell
303,101
-587,429
-66% -$19.8M 0.08% 257
2015
Q3
$28.1M Sell
890,530
-686,963
-44% -$33.5M 0.24% 147
2015
Q2
$76.3M Sell
1,577,493
-781,163
-33% -$32.9M 0.55% 53
2015
Q1
$102M Sell
2,358,656
-283,375
-11% -$10.2M 0.74% 34
2014
Q4
$69.5M Buy
2,642,031
+176,923
+7% +$3.88M 0.51% 60
2014
Q3
$43.8M Sell
2,465,108
-76,045
-3% -$1.55M 0.35% 103
2014
Q2
$61M Buy
2,541,153
+127,748
+5% +$2.59M 0.45% 72
2014
Q1
$60.6M Buy
2,413,405
+265,728
+12% +$7.36M 0.44% 75
2013
Q4
$48.9M Buy
2,147,677
+261,247
+14% +$5.28M 0.36% 98
2013
Q3
$42.7M Buy
+1,886,430
New +$43.5M 0.33% 108

Other funds holding PGEN

Frontier Capital Management's PGEN Position: Q4 2018 in Review

Frontier Capital Management sold out of Precigen (PGEN) in Q4 2018, closing a stake of 438,693 shares — an estimated $7.55M sold.

Frontier Capital Management first reported a position in PGEN in Q3 2013 and held it in 21 quarters. The position peaked at $102M in Q1 2015. 166 funds tracked by Wall St. Rank hold PGEN as of Q4 2018.

  • Frontier Capital Management reported no remaining Precigen position as of Q4 2018 after selling out during the quarter.
  • Frontier Capital Management sold 438,693 Precigen shares in Q4 2018, an estimated $7.55M.
  • Frontier Capital Management first reported a position in Precigen in Q3 2013 and held it in 21 quarters.
  • Frontier Capital Management's Precigen position peaked at $102M in Q1 2015.
  • 166 funds tracked by Wall St. Rank held Precigen as of Q4 2018.

Based on Frontier Capital Management's 13F filing for Q4 2018, filed 25 Jan 2019.